NO942301L - Imidazokinazolinforbindelser og deres fremstilling og anvendelse - Google Patents

Imidazokinazolinforbindelser og deres fremstilling og anvendelse

Info

Publication number
NO942301L
NO942301L NO942301A NO942301A NO942301L NO 942301 L NO942301 L NO 942301L NO 942301 A NO942301 A NO 942301A NO 942301 A NO942301 A NO 942301A NO 942301 L NO942301 L NO 942301L
Authority
NO
Norway
Prior art keywords
alkyl
alkoxyalkyl
alkoxy
substituted
compounds
Prior art date
Application number
NO942301A
Other languages
English (en)
Norwegian (no)
Other versions
NO942301D0 (no
Inventor
Holger Claus Hansen
Marit Kristiansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO942301D0 publication Critical patent/NO942301D0/no
Publication of NO942301L publication Critical patent/NO942301L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO942301A 1991-12-20 1994-06-17 Imidazokinazolinforbindelser og deres fremstilling og anvendelse NO942301L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK912042A DK204291D0 (da) 1991-12-20 1991-12-20 Heterocykliske forbindelser deres fremstilling og anvendelse
PCT/DK1992/000385 WO1993013103A1 (en) 1991-12-20 1992-12-18 Imidazoquinazoline compounds and their preparation and use

Publications (2)

Publication Number Publication Date
NO942301D0 NO942301D0 (no) 1994-06-17
NO942301L true NO942301L (no) 1994-08-19

Family

ID=8109668

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942301A NO942301L (no) 1991-12-20 1994-06-17 Imidazokinazolinforbindelser og deres fremstilling og anvendelse

Country Status (12)

Country Link
EP (1) EP0619820A1 (enrdf_load_stackoverflow)
JP (1) JPH07502278A (enrdf_load_stackoverflow)
AU (1) AU673814B2 (enrdf_load_stackoverflow)
CA (1) CA2125854A1 (enrdf_load_stackoverflow)
DK (1) DK204291D0 (enrdf_load_stackoverflow)
FI (1) FI942963A7 (enrdf_load_stackoverflow)
IL (1) IL104099A (enrdf_load_stackoverflow)
NO (1) NO942301L (enrdf_load_stackoverflow)
NZ (1) NZ246558A (enrdf_load_stackoverflow)
TW (1) TW211568B (enrdf_load_stackoverflow)
WO (1) WO1993013103A1 (enrdf_load_stackoverflow)
ZA (1) ZA929770B (enrdf_load_stackoverflow)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK151890D0 (da) * 1990-06-22 1990-06-22 Ferrosan As Heterocykliske forbindelser deres fremstilling og brug
CN1052724C (zh) * 1996-07-01 2000-05-24 瑞安大药厂股份有限公司 新的光学活性的2,3-二氢咪唑并[1,2-c]喹唑啉衍生物及其制备方法和用途
KR100864364B1 (ko) 2005-12-13 2008-10-17 주식회사 엘지화학 신규한 이미다조퀴나졸린 유도체, 이의 제조방법 및 이를이용한 유기전기소자
EP2125750B1 (en) 2007-02-26 2014-05-21 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
AR069207A1 (es) 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
US8440658B2 (en) 2007-12-11 2013-05-14 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
DK2324018T3 (da) 2008-07-25 2013-10-14 Boehringer Ingelheim Int Cykliske inhibitorer af 11 beta-hydroxysteroid dehydrogenase 1
TW201016691A (en) 2008-07-25 2010-05-01 Boehringer Ingelheim Int Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2010089303A1 (en) 2009-02-04 2010-08-12 Boehringer Ingelheim International Gmbh CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
US8927539B2 (en) 2009-06-11 2015-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
EP2448928B1 (en) 2009-07-01 2014-08-13 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
WO2011161128A1 (en) 2010-06-25 2011-12-29 Boehringer Ingelheim International Gmbh Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
CA2813671A1 (en) 2010-11-02 2012-05-10 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
JP2023545196A (ja) * 2020-10-16 2023-10-26 シャンハイ ドーァ ノボ ファーマテック カンパニー,リミティド 三複素環誘導体、その医薬組成物及び使用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1297099C (en) * 1985-10-17 1992-03-10 Frank Watjen Quinazoline compounds and their preparation and use
DK155524C (da) * 1987-03-18 1989-09-11 Ferrosan As Kondenserede imidazolderivater og farmaceutiske praeparater indeholdende disse
DK443589D0 (da) * 1989-09-08 1989-09-08 Ferrosan As Heterocykliske forbindelser, deres fremstilling og anvendelse
DK151890D0 (da) * 1990-06-22 1990-06-22 Ferrosan As Heterocykliske forbindelser deres fremstilling og brug

Also Published As

Publication number Publication date
IL104099A0 (en) 1993-05-13
EP0619820A1 (en) 1994-10-19
AU3344893A (en) 1993-07-28
NZ246558A (en) 1995-07-26
ZA929770B (en) 1994-06-17
FI942963L (fi) 1994-06-20
CA2125854A1 (en) 1993-07-08
WO1993013103A1 (en) 1993-07-08
JPH07502278A (ja) 1995-03-09
IL104099A (en) 1996-07-23
AU673814B2 (en) 1996-11-28
DK204291D0 (da) 1991-12-20
TW211568B (enrdf_load_stackoverflow) 1993-08-21
FI942963A0 (fi) 1994-06-20
FI942963A7 (fi) 1994-06-20
NO942301D0 (no) 1994-06-17

Similar Documents

Publication Publication Date Title
NO942301L (no) Imidazokinazolinforbindelser og deres fremstilling og anvendelse
FI912998A0 (fi) Foerfarande foer framstaellning av aralifatiskt n-substituerade aminoalkanfosfinsyror.
ES2188280T3 (es) Acetales heteroaril-ciclicos.
DE69420564D1 (de) Immunsuppressive und antiallergische verbindungen; z.b. n-(3-oxohexanoyl)-homoserinlacton
EP0482410A3 (en) Anti-microbial compounds, including substituted 2-cyclohexyl-amine derivatives and their preparation
NZ506787A (en) Trisubstituted 1,3,5-triazine derivatives having HIV replication inhibiting properties for treatment of HIV infections and preparation process thereof
HUT74367A (en) Fungicidal alpha-aryl-substituted cyclic amide derivatives, fungicid compositions containing these as active ingredients and using thereof
BR9815166A (pt) "método de inibição da replicação de vìrus, composto, método de inibição da replicação de citomegalovìrus, composto antiviral, utilização de um composto, composição farmacêutica, composição farmacêutica inibidora da replicação de vìrus e de citomegalovìrus e composição farmacêutica antiviral"
TW340115B (en) Triazine derivatives and pharmaceutical composition for hepatitis the invention relates to triazine derivatives and pharmaceutical composition for hepatitis
ZA842185B (en) New n-aryl-n'-cycloalkylalkanoyl-piperazine and process for the production thereof
NZ503912A (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
ES8607300A1 (es) Acidos 1,7-diamino-1,4-dihidro-4-oxo-3-(aza) quinolincarbo- xilicos
BR9913183A (pt) Composto, uso do mesmo, processo para prepará-lo, processo para tratar um indivìduo humano ou animal, e, composição farmacêutica
ATE88700T1 (de) Kondensierte pyrazol-3-oxo-propannitril-derivate und verfahren zu deren herstellung.
TW333532B (en) Benzopyrans
ATE119910T1 (de) Amphotericin b derivate.
MX9702089A (es) Carboxamidas biciclicas como antagonistas de 5-ht1a.
DK0451626T3 (da) Anvendelse af benzodiazepinforbindelser til fremstilling af et farmaceutisk præparat mod med excitatoriske aminosyrer forbundne forstyrrelser i centralnervesystemet
TW282458B (enrdf_load_stackoverflow)
NO933162D0 (no) Heterosykliske forbindelser samt fremgangsm}te for fremstilling av slike
KR870006898A (ko) 신장염 치료제
MX9602306A (es) Derivados de n-[(1,4-diazabiciclo[2.2.2]oct-2-il) metil]benzamida, su preparacion y su aplicacion en terapeutica.